EMEA-001238-PIP03-21-M01 - paediatric investigation plan

Vatiquinone
PIPHuman

Key facts

Active Substance
Vatiquinone
Therapeutic area
Neurology
Decision number
P/0192/2023
PIP number
EMEA-001238-PIP03-21-M01
Pharmaceutical form(s)
  • Oral solution
  • Capsule, hard
Condition(s) / indication(s)
Treatment of Friedreich's ataxia
Route(s) of administration
Oral use
Contact for public enquiries

PTC Therapeutics International Limited

Tel. +353 19068700
E-mail: medinfo@ptcbio.com

Decision type
PM: decision on the application for modification of an agreed PIP
Decision date

Decision

Share this page